Vcanbio Cell & Gene Engineering Corp., Ltd. Class ASSE: 600645

"Vcanbio Cell & Gene Engineering Corp., Ltd."Announcement on Measures in the Form of Warning Letters Received by the Company and Relevant Persons

Sep 16, 2026 · Issued by Vcanbio Cell & Gene Engineering Corp., Ltd. Class A via Shanghai Stock Exchange

Announcement on Measures in the Form of Warning Letters Received by the Company and Relevant Persons

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Earlier from Vcanbio Cell & Gene Engineering Corp., Ltd. Class A

"Vcanbio Cell & Gene Engineering Corp., Ltd."Announcement on Attending the 2026 Online Collective Reception Day for Investors of Listed Companies in Tianjin Jurisdiction and Semi-annual Performance BriefingAug 28
"Vcanbio Cell & Gene Engineering Corp., Ltd."Announcement on Reply to Letter of Supervision and Inquiry on Information Disclosure of 2025 Annual ReportJul 31
"Vcanbio Cell & Gene Engineering Corp., Ltd."Announcement on Progress in Wholly-owned Subsidiary's Clinical Trial for VUM02 InjectionJul 18
"Vcanbio Cell & Gene Engineering Corp., Ltd"Announcement on Progress in Redemption of Temporarily Idle Raised Funds Used for Cash Management upon Expiration and Continuously Conducting Cash ManagementJul 2

All Vcanbio Cell & Gene Engineering Corp., Ltd. Class A news releases